Lv2
178 积分 2022-05-06 加入
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
2个月前
已完结
Semaglutide and Tirzepatide for the Management of Weight Recurrence After Sleeve Gastrectomy: A Retrospective Cohort Study
2个月前
已完结
Home blood pressure-centered approach – from digital health to medical practice: HOPE Asia Network consensus statement 2023
5个月前
已完结
皖公网安备34019202002308
